Technical Analysis for GOVX - GeoVax Labs, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Lower Bollinger Band Walk | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | 2.54% | |
NR7 | Range Contraction | 2.54% | |
Lower Bollinger Band Walk | Weakness | 2.54% | |
Inside Day | Range Contraction | 2.54% | |
Wide Bands | Range Expansion | 2.54% | |
Down 3 Days in a Row | Weakness | 2.54% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Lower Bollinger Band Support | about 19 hours ago |
60 Minute Opening Range Breakdown | about 19 hours ago |
2x Volume Pace | about 19 hours ago |
1.5x Volume Pace | about 19 hours ago |
Down 5% | about 19 hours ago |
Get a Trading Sidekick!
- Earnings date: 11/07/2023
GeoVax Labs, Inc. Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform in the United States and internationally. It is developing various preventive vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; the HIV Vaccines Trial Network; Centers for Disease Control and Prevention; U.S. Army Research Institute of Infectious Disease; U.S. Naval Research Laboratory; Emory University; University of Pittsburgh; Georgia State University Research Foundation; University of Texas Medical Branch; the Institute of Human Virology at the University of Maryland; the Scripps Research Institute; the Burnet Institute; American Gene Technologies, Inc.; Viamune, Inc.; Vaxeal Holding SA; CaroGen Corporation; Virometix AG; U.S. Department of Defense; Geneva Foundation; Enesi Pharma; and Leidos, Inc. GeoVax Labs, Inc. was founded in 2001 and is based in Smyrna, Georgia.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Clinical Medicine Infectious Diseases Immunotherapies Vaccines Hepatitis B Allergy Department Of Defense Viruses HIV Immunodeficiency Virus Malaria U.S. Department Of Defense Virology Fever Ebola Zika Chronic Hepatitis Scripps Vaccinia
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.39 |
52 Week Low | 0.36 |
Average Volume | 220,837 |
200-Day Moving Average | 0.59 |
50-Day Moving Average | 0.51 |
20-Day Moving Average | 0.49 |
10-Day Moving Average | 0.44 |
Average True Range | 0.04 |
RSI (14) | 28.06 |
ADX | 30.53 |
+DI | 6.89 |
-DI | 32.57 |
Chandelier Exit (Long, 3 ATRs) | 0.46 |
Chandelier Exit (Short, 3 ATRs) | 0.47 |
Upper Bollinger Bands | 0.60 |
Lower Bollinger Band | 0.37 |
Percent B (%b) | 0.13 |
BandWidth | 47.95 |
MACD Line | -0.03 |
MACD Signal Line | -0.02 |
MACD Histogram | -0.0118 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.47 | ||||
Resistance 3 (R3) | 0.47 | 0.44 | 0.46 | ||
Resistance 2 (R2) | 0.44 | 0.42 | 0.44 | 0.46 | |
Resistance 1 (R1) | 0.42 | 0.41 | 0.43 | 0.42 | 0.45 |
Pivot Point | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 |
Support 1 (S1) | 0.37 | 0.37 | 0.38 | 0.38 | 0.35 |
Support 2 (S2) | 0.34 | 0.36 | 0.34 | 0.34 | |
Support 3 (S3) | 0.32 | 0.34 | 0.34 | ||
Support 4 (S4) | 0.33 |